13F Holdings
中文EN

OMDA Omada Health, Inc.

Services-Health Services · Nasdaq · SEC CIK 1611115 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY43.3%
TTM net income YoY153.6%
TTM EPS YoY124.5%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin70.7%
Operating margin2.1%
Net margin4.2%
FCF margin8.5%
EBITDA margin3.9%

Returns

ROE5.7%
ROA4.4%
ROIC (approx.)28.2%
Asset turnover1.05x

Leverage & solvency

Liabilities / assets21.6%
Debt / equity0.00x
Current ratio4.18x
Interest coverage22.37x

Cash quality & payout

Operating cash flow / net income2.04x
Accruals ratio-4.6%
Payout ratio—
Capex / revenue0.2%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31
Income statement
Revenue$260.21M$169.80M$122.78M
Cost of revenue$89.27M$66.92M$52.81M
Gross profit$170.94M$102.88M$69.97M
R&D expense$40.68M$35.92M$33.74M
SG&A expense$52.18M$42.55M$35.98M
Operating income-$11.97M-$43.65M-$66.00M
Interest expense$2.53M$4.51M$4.71M
Pretax income-$12.78M-$47.14M-$67.51M
Income tax$0$0$0
Net income-$12.78M-$47.14M-$67.51M
EBITDA-$6.48M-$38.85M-$61.55M
EPS (basic)-0.35-6.11-9.52
EPS (diluted)-0.35-6.11-9.52
Weighted avg. shares (diluted)36.64M7.72M7.09M
Balance sheet
Cash & equivalents$222.04M$76.39M$115.64M
Receivables$34.59M$23.42M—
Inventory$4.49M$3.30M—
Current assets$272.93M$113.06M—
PP&E, net$7.94M$5.62M—
Goodwill$13.24M$13.24M—
Intangibles$2.41M$4.26M—
Total assets$305.41M$150.89M—
Current liabilities$75.73M$53.95M—
Long-term debt$0$29.77M—
Total debt$0$29.77M—
Total liabilities$75.73M$86.26M—
Shareholders' equity$229.68M-$384.40M-$350.11M
Net debt-$222.04M-$46.62M—
Shares outstanding58.43M8.16M—
Cash flow statement
Operating cash flow$18.25M-$34.18M-$49.74M
Capital expenditure$1.32M$596,000$416,000
Free cash flow$16.93M-$34.77M-$50.15M
Investing cash flow-$5.83M-$3.86M-$2.92M
Financing cash flow$133.22M-$1.21M$179,000
Depreciation & amortization$5.49M$4.80M$4.45M
Stock-based compensation$12.96M$9.42M$8.74M

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.